Concepedia

Author

Catherine Duvernelle

Inserm

Also Known As

C. Duvernelle, Catherine Duvernelle

9

Publications

575

Citations

8

H-Index

20

Concepts

All Affiliations

InsermHôpitaux Universitaires de StrasbourgInstitut d’Hématologie et d’Oncologie PédiatriqueUCB Pharma (France)Laboratoire de Biophotonique et Pharmacologie
CD

About

Catherine Duvernelle is an author at Inserm specializing in medicine, dermatology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

131

2

Health Sciences

1

1

69

3

Allergy

1

1

69

4

Cell Biology

1

1

69

5

Cellular Physiology

1

1

69

Catherine Duvernelle

×

7

Publications

436

Citations

7

H-Index

YearCitations

Nerve growth factor levels and localisation in human asthmatic bronchi

C. Olgart Höglund, F. de Blay, JP Oster,

European Respiratory Journal

2002

116

Local increase in the number of mast cells and expression of nerve growth factor in the bronchus of asthmatic patients after repeated inhalation of allergen at low‐dose

Olivier Kassel, F. de Blay, Catherine Duvernelle,

Clinical & Experimental Allergy

2001

111

Human bronchial smooth muscle cells in culture produce stem cell factor

Olivier Kassel, Fabien Schmidlin, Catherine Duvernelle,

European Respiratory Journal

1999

69

Twenty-four hours of activity of cetirizine and fexofenadine in the skin

Ashok Purohit, Catherine Duvernelle, Michel Mélac,

Annals of Allergy Asthma & Immunology

2001

49

Up- and Down-Regulation by Glucocorticoids of the Constitutive Expression of the Mast Cell Growth Factor Stem Cell Factor by Human Lung Fibroblasts in Culture

Olivier Kassel, Fabien Schmidlin, Catherine Duvernelle,

Molecular Pharmacology

1998

41

Repeated Inhalation of Low Doses of Cat Allergen That Do Not Induce Clinical Symptoms Increases Bronchial Hyperresponsiveness and Eosinophil Cationic Protein Levels

F. de Blay, Pascale Krieger, F. Spirlet,

International Archives of Allergy and Immunology

1999

37

Consistency and efficacy of cetirizine (10 mg) versus ebastine (20 mg) at 4 h on skin reactivity

Ashok Purohit, Catherine Duvernelle, Michel Mélac,

European Journal of Clinical Pharmacology

1999

13

Page 1